Hiroyuki Matsubayashi

39PUBLICATIONS
43CO-AUTHORS
Cancer geneticsMicro- and nanosystemsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nanometrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Feb 15, 2026
Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.

Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Eiko Ishihara

|Oct 21, 2025
Diagnosis and treatment strategies for hereditary pancreatic cancer syndrome.

Hiroyuki Matsubayashi, Chigusa Morizane, Masashi Kanai

|May 14, 2025
Factors affecting the implementation of cascade testing of patients with BRCA1 or BRCA2 pathogenic germline variants in Japan.

Yoshimi Kiyozumi, Seiichiro Nishimura, Nobuhiro Kado

|Mar 04, 2025
The Time Lag Associated With the Reclassification of Germline BRCA Variants' Pathogenicity Is Critical for Cancer Patients.

Tomomi Hayashi, Hiroyuki Matsubayashi, Yoshimi Kiyozumi

|Jan 21, 2025
A Japanese family of hereditary diffuse gastric cancer with a germline pathogenic variant of CTNN1A detected via comprehensive genome profiling.

Takeshi Kawakami, Hiroyuki Matsubayashi, Yoshimi Kiyozumi

Pageof 7